• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

R-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3) details
Primary information
ID antitb_1335,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineIC50 = <0.0125 μg/mL (50%)
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL male mice and male beagle dogs
Mechanism of Action10 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1336,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium intracellulare
In Vitro/ In vivoMycobacterium intracellulare
Cell LineIC50 = 1.56 μg/mL (50%)
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL male mice and male beagle dogs
Mechanism of Action11 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1337,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium kansasii
In Vitro/ In vivoMycobacterium kansasii
Cell LineIC50= 0.39 μg/mL (50%)
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL male mice and male beagle dogs
Mechanism of Action12 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1338,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineIC90= 0.05 μg/mL(90%)
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL male mice and male beagle dogs
Mechanism of Action13 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1339,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium intracellulare
In Vitro/ In vivoMycobacterium intracellulare
Cell LineIC90= 0.78 μg/mL(90%)
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL male mice and male beagle dogs
Mechanism of Action14 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1340,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium kansasii
In Vitro/ In vivoMycobacterium kansasii
Cell LineIC90= 0.78 μg/mL(90%)
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL male mice and male beagle dogs
Mechanism of Action15 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1341,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium bovis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL Mice
Mechanism of Action15 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMID4mg of DHMPA peptide+ 0.1 mg of Isoniazid
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1342,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis R-KM
Inhibition ConcentrationBoth
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceICR/JCL Mice
Mechanism of Action15 mg/kg for mice and 50mg/kg for dog
TargetNA
Combination TherapyNA
Other activitiesNA
PMID4mg of DHMPA peptide+ 0.1 mg of Isoniazid
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1343,
Name3348603
N-Terminal modificationDihydromycoplanecin A
C-Terminal ModificationR-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3)
Chemical ModificationPropanol is attached
Linear/CyclicFree
LengthR =CH3-CH2-CH(OH)-CO
ChiralityCyclic
Nature21
SourceMix
SpeciesNatural
StrainAspergillus awajinensis
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis ATCC 607
Cell LineFIC= 0.250 - 0.375
Sequence1988
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDDHMPA+ Isoniazid
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),